Amagma Therapeutics

Waltham, United States

Amagma Therapeutics specializes in the discovery and development of antibody therapeutics against inflammatory diseases.

$2.3M raised

Jun 2022

Venture - Series Unknown

Biotechnology Health Diagnostics Medical

Top Investors

Polaris Partners Magnetic Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amagma Therapeutics

How much funding has Amagma Therapeutics raised?

Amagma Therapeutics has raised $2.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2022.

Who are Amagma Therapeutics's investors?

Amagma Therapeutics's investors include Polaris Partners, Magnetic Ventures.

Where is Amagma Therapeutics headquartered?

Amagma Therapeutics is headquartered in Waltham, United States.

What does Amagma Therapeutics do?

Amagma Therapeutics specializes in the discovery and development of antibody therapeutics against inflammatory diseases.

What stage is Amagma Therapeutics at?

Amagma Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 1, 2022.

MLA

"Amagma Therapeutics — Funding & Investors." VCBacked, June 1, 2022, https://www.vcbacked.co/company/amagma-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Amagma Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/amagma-therapeutics

Wikipedia (cite web)

{{cite web |title=Amagma Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amagma-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 1, 2022.